Day 1 :
Beverly Hills Breast and Body institute, USA
Time : 09:00 AM
Dr. Jaime S. Schwartz MD, FACS, is a board-certified plastic surgeon, a member of the American Society of Plastic Surgeons, and a diplomate of the American Board of Plastic Surgery. He is widely known for fixing some of the most complex breast surgery problems in the industry and is considered the surgeon that other plastic surgeons turn to for education on aesthetic and reconstructive surgery. After completing his 6-year plastic and reconstructive surgery residency at Georgetown University Hospital, he was given a fellowship in advanced breast and body aesthetics at the internationally renowned Cleveland Clinic, where he held an appointment as a clinical instructor. Some of Dr. Schwartz’s accomplishments include developing U.S. National Guidelines for breast surgeries and creating the LipoLift® procedure (featured on The Doctors TV show).
Dr. Schwartz created the LipoLift® breast procedure to provide patients with a safer, less-invasive, breast lift and reduction option. As the pioneer of the LipoLift® technique, Dr. Schwartz has given lectures across the United States and even appeared on television programs like The Doctors TV show to discuss this revolutionary procedure.
Similar to a traditional breast reduction, the LipoLift® can make the breasts smaller, but it differs in its ability to leave more of the natural blood and nerve supply intact. The LipoLift® procedure uses liposuction of the lower and outer portions of the breasts, eliminating the parts of the breast that most women are dissatisfied with—the sides and bottom—while preserving upper-pole fullness. This technique allows Dr. Schwartz to blend and remove axillary and lateral tissue while at the same time effectively moving tissue from the bottom to the top, which makes the breasts more attractive.
LipoLift® is minimally invasive, p andatients typically don’t lose any nipple sensitivity with LipoLift®, and most state that they even have hypersensitivity of the nipples following surgery. LipoLift® is ideal for improving breast symmetry, as the technique provides far greater precision than other breast techniques, which allows Dr. Schwartz to make subtle changes that dramatically impact the appearance of the breasts. This advanced technique is less invasive, safer if someone needs a revision breast reduction, and just as effective as other breast lift and reduction techniques.
Beautiful Skin Institute PLLC, Herndon, VA 20170, USA
Keynote: Acne Scar Reduction: What is New?
Time : 09:40 AM
Dr. Clemens Esche is a board-certified dermatologist who graduated from The Johns Hopkins dermatology program and held faculty appointments at the University of Pittsburgh, the Mayo Clinic and at The Johns Hopkins University.
Dr. Esche has received more than 10 academic awards for his pioneering research and has authored more than 70 publications. He is a thought after keynote speaker and will deliver keynotes at the 2nd Euro-Global Congress on Melanoma and Skin Diseases on August 31th, 2017, in London, UK, and at the 13th International Conference and Exhibition on Cosmetic Dermatology & Hair Care on October 26th, 2017, in Paris, France.
Dr. Esche was recognized with the Patient’s Choice Award in 2013 and became the National Winner of the Doctor’s Choice Award in 2014 and again in 2015. Dr. Esche has been featured in Marquis’ Who’s Who in Medicine and Healthcare and in Marquis’ Who’s Who in America. He serves on the Editorial Board of the Journal of Surgical Dermatology and of the Journal of Procedural Dermatology.
Dr. Esche treats adult, pediatric and cosmetic patients and specializes in minimally invasive cosmetic procedures with little to zero downtime. Dr. Esche takes a holistic approach to improve the overall appearance as opposed to just focusing on certain lines and wrinkles. Convinced that ‘less is more’ Dr. Esche strives to achieve the most natural result possible.
Inflammation is the single greatest reason for acne scar development. Consequently, the extent of scarring is associated with acne severity and delay in treatment. Each scar is different and therefore requires a customized approach.
Acne scars are currently classified into 3 different types:
(i) atrophic, (ii) hypertrophic and (iii) keloidal
A net destruction of collagen in the dermis results in atrophic nscarring. It can be further classified as ice-pick (narrow and deep, 60%), boxcar (1.5-4 mm wide, 25%) or rolling (15%). Less commonly, there is a net gain of collagen that results in hypertrophic or keloidal scars.
Ice-pick (deep pit) scars are frequently the most severe, and, unfortunately, represent around 2/3 of cases.
Fraxel or CO2 laser treatment have been considered the gold standard until recently . However, fractional radiofrequency and also the Chemical Reconstruction of Skin Scars (CROSS) technique tend to be superior to even the most advanced fractional laser for the treatment of ice pick and deep scarring. They also tend to work well for boxcar and deep rolling scars. Four treatments at monthly intervals will serve many patients well.
An added benefit is the shorter recovery time compared with Fraxel laser. TCA CROSS involves a high-strength TCA peel (50-100%) applied to the base of the scar to ablate the epithelial wall and to promote dermal remodeling. The degree of clinical improvement is proportional to the number of sessions.
Hypertrophic and keloidal scars can be injected with corticosteroids, 5-fluorouracil, bleomycin or verapamil. Alternatives include silicone dressings and cryotherapy. Freezing from within with cryoshape is advocated periodically.
Numerous 2017 publications challenge the cosmetic procedural delay following oral isotretinoin therapy. An algorithmic approach summarizes the updated recommendations.
152 Harley street, London, UK
Dr Firas Al-Niaimi is a highly experienced consultant dermatologist with over 15 years’ experience and an international standing and trained in some of the UK's top hospitals. Hes has a passion for education, research and science & has over 150 publications in Dermatology and lasers (including on filler complications) making him one of the most prolific and well-published consultant dermatologists in the UK. In addition to this he has more than 200 scientific presentations all around the world where he is regularly invited to speak in addition to several chapters of books and his own book.
Botulinum neurotoxin (BoNT) is renowned for its inhibitory effects on the neuromuscular junction and is widely used in cosmetic dermatology. The evidence for its use in cosmetic dermatology and in non-dermatological indications is well established and more and more applications of its use beyond cosmetics are being discovered. In this presentation the currect evidence for the non-cosmetic dermatological uses of BoNT will be presented as well as my own personal; experience. The use is ion a multitude of dermatological diseases, including (but not limited to) hyperhidrosis, Darier’s disease, Hailey-Hailey disease, pompholyx, scarring, rosacea and hidradenitis suppurativa. Tips regarding the method of use and combination treatments will be discussed.
Celal Bayar University,Turkey
He completed medical education in Erciyes University Medical Faculty, Kayseri, Turkey in 1989. His dermatology residency was in Dokuz Eylül University Medical Faculty, Izmir, Turkey between 1992-1997.He is currently working as a professor in the Celal Bayar University Medical Faculty Department of Dermatology, Manisa, Turkiye.He is the member of Dermatovenereology Association of Turkey, Turkish Dermatology Association, Turkish Dermatopathology Association, Turkish Skin and Venereologic Diseases Association, International Society of Dermatology (ISD), European Academy of Dermatology and Venereology (EADV), American Academy of Dermatology (AAD) (Since 2001). Moreover, I am also a board member in International Dermoscopy Society (IDS).
Hair loss is the most common hair problem and a prompt diagnosis of the type of alopecia may sometimes be extremely challenging. Methods commonly used to investigate may be invasive (biopsy), semi invasive (trichogram) or non-invasive (hair count, weighing shed hair and pull test). 'Trichoscopy' represents a valuable, noninvasive technique for the evaluation of patients with hair loss. It allows for magnified visualization of the hair and scalp skin, and may be performed with a manual dermoscope or a videodermoscope. The usual working magnifications are 20-fold to 70-fold. Although the hand-held dermoscope with 10-fold magnification may give easy and quick evaluation of hair, it does not precisely measure or document. Trichoscopic observations can be broadly grouped as hair signs, vascular patterns, pigment patterns and interfollicular patterns. In this presentation, we will briefly describe the trichoscopic findings in the common categories of cicatricial and non-cicatricial alopecias such as androgenetic alopecia, alopecia areata, telogen effluvium, tinea capitis, trichotillomania, lichen planopilaris, discoid lupus erythematosus and hair shaft disorders. This method is simple, quick and easy to perform, reduces the need for scalp biopsy, is well accepted by patients, and is useful for monitoring treatment and follow-up. It represents a valuable link between clinical and histologic diagnosis. New data show that trichoscopy may easily replace light microscopic evaluation of pulled hairs in genetic hair shaft abnormalities.